These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18827757)

  • 1. Treatment of psychotic disorders with aripiprazole in the emergency psychiatric setting.
    Raja M; Azzoni A
    Psychiatr Danub; 2008 Sep; 20(3):323-8. PubMed ID: 18827757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
    Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of combining aripiprazole to clozapine: three case reports.
    Rocha FL; Hara C
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1167-9. PubMed ID: 16647796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of aripiprazole in tardive dyskinesia: an open label study of six cases.
    Rajarethinam R; Dziuba J; Manji S; Pizzuti A; Lachover L; Keshavan M
    World J Biol Psychiatry; 2009; 10(4 Pt 2):416-9. PubMed ID: 19492247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
    Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study.
    Kwon JS; Jang JH; Kang DH; Yoo SY; Kim YK; Cho SJ;
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):73-81. PubMed ID: 19154213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who responds to aripiprazole in clinical practice? An observational study of combination versus monotherapy.
    Shajahan P; Macrae A; Bashir M; Taylor M
    J Psychopharmacol; 2008 Sep; 22(7):778-83. PubMed ID: 18308790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine augmentation with aripiprazole for negative symptoms.
    Clarke LA; Lindenmayer JP; Kaushik S
    J Clin Psychiatry; 2006 Apr; 67(4):675-6. PubMed ID: 16669737
    [No Abstract]   [Full Text] [Related]  

  • 9. Aripiprazole as an adjunct to clozapine therapy in adolescents with early-onset schizophrenia: a retrospective chart review.
    Bachmann CJ; Lehr D; Theisen FM; Preiss M
    Pharmacopsychiatry; 2009 Jul; 42(4):153-7. PubMed ID: 19585394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.
    Keck PE; Orsulak PJ; Cutler AJ; Sanchez R; Torbeyns A; Marcus RN; McQuade RD; Carson WH;
    J Affect Disord; 2009 Jan; 112(1-3):36-49. PubMed ID: 18835043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.
    Friedman JH; Berman RM; Goetz CG; Factor SA; Ondo WG; Wojcieszek J; Carson WH; Marcus RN
    Mov Disord; 2006 Dec; 21(12):2078-81. PubMed ID: 17013906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML; Shen WW; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of aripiprazole, olanzapine, quetiapine, and risperidone augmentation treatment for major depressive disorder: a nationwide population-based study.
    Lin CY; Tsai GE; Wang HS; Wu YH; Chiou CC; Wu VY; Lane HY
    J Clin Psychiatry; 2014 Sep; 75(9):e924-31. PubMed ID: 25295435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
    Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
    J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine augmented with aripiprazole in 5 patients with schizophrenia.
    Abu-Tair F; Kopitz J; Bergemann N
    J Clin Psychopharmacol; 2006 Dec; 26(6):669-71. PubMed ID: 17110831
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder.
    Bellino S; Paradiso E; Bogetto F
    Psychiatry Res; 2008 Nov; 161(2):206-12. PubMed ID: 18848360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, 4-week study.
    Zimbroff D; Warrington L; Loebel A; Yang R; Siu C
    Int Clin Psychopharmacol; 2007 Nov; 22(6):363-70. PubMed ID: 17917555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA).
    Tandon R; Marcus RN; Stock EG; Riera LC; Kostic D; Pans M; McQuade RD; Nyilas M; Iwamoto T; Crandall DT
    Schizophr Res; 2006 May; 84(1):77-89. PubMed ID: 16483745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of inpatient treatment continuation and hospital readmission rates in patients with bipolar disorder treated with aripiprazole or quetiapine.
    Kreys TJ; Fabian TJ; Saul MI; Haskett R; Coley KC
    J Psychiatr Pract; 2013 Jul; 19(4):288-95. PubMed ID: 23852103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.